Efficacy and safety of three antiretroviral therapy regimens started in pregnancy through 50 weeks postpartum: a multicentre, open-label, randomised controlled, phase 3 trial
Lameck Chinula, Ziemba Lauren, Sean Brummel, Katie McCarthy, Anne Coletti, Chelsea Krotje, Benjamin Johnston, Kevin Knowles, Sikhulile Moyo, Lynda Stranix-Chibanda, Risa Hoffman, Paul E. Sax, Jeffrey Stringer, Nahida Chakhtoura, Patrick Jean-Philippe, Violet Korutaro, Haseena Cassim, Lee Fairlie, Gaerolwe Masheto, Ceejay Boyce, Lisa M. Frenkel, K Rivet Amico, Lynette Purdue, Roger Shapiro, Blandina Theophil Mmbaga, Faeezah Patel, Jean van Wyk, James F. Rooney, Judith S. Currier, Shahin Lockman
Lancet HIV.
Author manuscript; available in PMC 2024 Jun 1.Published in final edited form as: Lancet HIV. 2023 Jun; 10(6): e363–e374. Published online 2023 May 8. doi: 10.1016/S2352-3018(23)00061-9